HF
ODT

HRT Financial’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

HRT Financial’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,761
Closed -$72K – 4445
2021
Q3 		$72K Sell
24,761
-17,957
-42% -$59.7K ﹤0.01% 2986
2021
Q2 		$149K Buy
+42,718
New +$147K ﹤0.01% 2493

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

HRT Financial's ODT Position: Q4 2021 in Review

HRT Financial sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2021, closing a stake of 24,761 shares — an estimated $72K sold.

HRT Financial first reported a position in ODT in Q2 2021 and held it in 2 quarters. The position peaked at $149K in Q2 2021. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • HRT Financial reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 24,761 Odonate Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $72K.
  • HRT Financial first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • HRT Financial's Odonate Therapeutics, Inc. Common Stock position peaked at $149K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.